Exercise Training Combined with Angiotensin II Receptor Blockade Limits Post-infarct Ventricular Remodelling in Rats
Overview
Authors
Affiliations
Aims: Our aim was to test the hypothesis that angiotensin II receptor blockade combined with exercise training after myocardial infarction (MI) could attenuate post-MI left ventricular remodelling and preserve cardiac function.
Methods And Results: Sprague-Dawley rats underwent ligation of the left descending coronary artery, resulting in MI, or a sham operation. Losartan treatment and exercise training were initiated 1 week after infarction and continued for 8 weeks, either as a single intervention or combined. Collagen volume fraction in the sedentary MI (MISed) group was significantly higher than other MI groups treated with exercise training and/or losartan. Compared with MISed group, hearts of rats receiving exercise and/or losartan treatment had lower tissue inhibitor of matrix metalloproteinase (TIMP) 1. Matrix metalloproteinase (MMP) 2 or MMP-9 did not differ among all groups. Additionally, the level of angiotensin II receptor type 1 (AT1) protein significantly decreased in response to exercise training. Furthermore, angiotensin converting enzyme (ACE) binding was markedly lower in hearts receiving exercise training than in the MISed hearts. Cardiac function was preserved in rats receiving exercise training, and the beneficial effect was further improved by exercise combined with losartan treatment in comparison to the MISed group.
Conclusion: Our results suggest that post-MI exercise training and/or AngII receptor blockade reduces TIMP-1 expression and mitigates the expressions of ACE and AT1 receptor. These improvements, in turn, attenuate myocardial fibrosis and preserve post-MI cardiac function.
Habibian M, Biniaz S, Moosavi S Cardiovasc Toxicol. 2023; 23(5-6):177-184.
PMID: 37184829 DOI: 10.1007/s12012-023-09792-8.
Molecular mechanisms of exercise contributing to tissue regeneration.
Chen J, Zhou R, Feng Y, Cheng L Signal Transduct Target Ther. 2022; 7(1):383.
PMID: 36446784 PMC: 9709153. DOI: 10.1038/s41392-022-01233-2.
Batista D, Polegato B, da Silva R, Claro R, Azevedo P, Fernandes A Oxid Med Cell Longev. 2020; 2020:5041791.
PMID: 32765807 PMC: 7387991. DOI: 10.1155/2020/5041791.
Strength training attenuates post-infarct cardiac dysfunction and remodeling.
Garza M, Wason E, Cruger J, Chung E, Zhang J J Physiol Sci. 2019; 69(3):523-530.
PMID: 30911900 PMC: 10717786. DOI: 10.1007/s12576-019-00672-x.
Winter S, Macedo R, Francisco J, Santos P, Lopes A, de Meira L Arq Bras Cardiol. 2018; 110(4):373-380.
PMID: 29538503 PMC: 5941962. DOI: 10.5935/abc.20180036.